Hepatocellular Carcinoma, New England Journal of Medicine, vol.365, issue.12, pp.1118-1145, 2011. ,
DOI : 10.1056/NEJMra1001683
Hepatocellular carcinoma: clinical frontiers and perspectives, Gut, vol.19, issue.(Suppl 9), pp.844-55, 2014. ,
DOI : 10.1136/gutjnl-2013-306627
Advances in targeted therapies for hepatocellular carcinoma in the genomic era, Nature Reviews Clinical Oncology, vol.26, issue.7, pp.408-432, 2015. ,
DOI : 10.1158/1078-0432.CCR-13-2107
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3, Nature Reviews Cancer, vol.25, issue.7, pp.463-75, 2009. ,
DOI : 10.1038/nrc2656
The HER3/ErbB3 receptor: A promising target in cancer drug therapy, Gastroent??rologie Clinique et Biologique, vol.34, issue.4-5, pp.255-264, 2010. ,
DOI : 10.1016/j.gcb.2010.03.002
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics, Seminars in Cell & Developmental Biology, vol.21, issue.9, pp.944-50, 2010. ,
DOI : 10.1016/j.semcdb.2010.08.007
ErbB-3 Predicts Survival in Ovarian Cancer, Journal of Clinical Oncology, vol.24, issue.26, pp.4317-4340, 2006. ,
DOI : 10.1200/JCO.2005.04.8397
Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort, Cancer, vol.12, issue.11, pp.2400-2409, 2009. ,
DOI : 10.1002/cncr.24277
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients, The Breast, vol.23, issue.5, pp.637-680, 2014. ,
DOI : 10.1016/j.breast.2014.06.011
HER3 Is a Determinant for Poor Prognosis in Melanoma, Clinical Cancer Research, vol.14, issue.16, pp.5188-97, 2008. ,
DOI : 10.1158/1078-0432.CCR-08-0186
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome, Journal of Clinical Oncology, vol.29, issue.22, pp.3030-3036, 2011. ,
DOI : 10.1200/JCO.2010.33.6313
High Expression of HER3 Is Associated with a Decreased Survival in Gastric Cancer, Clinical Cancer Research, vol.14, issue.23, pp.7843-7852, 2008. ,
DOI : 10.1158/1078-0432.CCR-08-1064
Neuregulin-1-Mediated Autocrine Signaling Underlies Sensitivity to HER2 Kinase Inhibitors in a Subset of Human Cancers, Cancer Cell, vol.20, issue.2, pp.158-72, 2011. ,
DOI : 10.1016/j.ccr.2011.07.011
High Heregulin Expression Is Associated with Activated HER3 and May Define an Actionable Biomarker in Patients with Squamous Cell Carcinomas of the Head and Neck, PLoS ONE, vol.333, issue.2, p.56765, 2013. ,
DOI : 10.1371/journal.pone.0056765.s004
Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients, British Journal of Cancer, vol.5, issue.12, pp.2034-2075, 2004. ,
DOI : 10.1038/35052073
Nuclear HER3 is associated with favorable overall survival in uveal melanoma, International Journal of Cancer, vol.47, issue.5, pp.1120-1127, 2012. ,
DOI : 10.1002/ijc.26118
HGF and NRG1 protein expression are not poor prognostic markers in surgically resected lung adenocarcinoma, OncoTargets and Therapy, vol.8, pp.1185-91, 2015. ,
DOI : 10.2147/OTT.S78116
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma, British Journal of Cancer, vol.84, issue.10, pp.1377-83, 2001. ,
DOI : 10.1054/bjoc.2000.1580
Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach, Hepatology, vol.29, issue.Suppl, pp.944-53, 2004. ,
DOI : 10.1002/hep.20105
Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma, Hepatology, vol.68, issue.Suppl 1, pp.504-520, 2011. ,
DOI : 10.1002/hep.24083
Mitogenic Insulin Receptor-A Is Overexpressed in Human Hepatocellular Carcinoma due to EGFR-Mediated Dysregulation of RNA Splicing Factors, Cancer Research, vol.73, issue.13, pp.3974-86, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-3824
Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells, Journal of Hepatology, vol.57, issue.1, pp.108-123, 2012. ,
DOI : 10.1016/j.jhep.2012.02.019
Production of Infectious Hepatitis C Virus in Primary Cultures of Human Adult Hepatocytes, Gastroenterology, vol.139, issue.4, pp.1355-64, 2010. ,
DOI : 10.1053/j.gastro.2010.06.058
Hepatic Expression of ErbB3 Is Repressed by Insulin in a Pathway Sensitive to PI-3 Kinase Inhibitors, Endocrinology, vol.138, issue.12, pp.5195-201, 1997. ,
DOI : 10.1210/en.138.12.5195
Regulation of ERBB3/HER3 signaling in cancer, Oncotarget, vol.5, issue.21, pp.10222-10258, 2014. ,
DOI : 10.18632/oncotarget.2655
Hepatitis B virus X protein reduces the stability of Nrdp1 to up-regulate ErbB3 in hepatocellular carcinoma cells, Tumor Biology, vol.35, issue.8 ,
DOI : 10.1007/s13277-016-4936-y
Secreted ERBB3 Isoforms Are Serum Markers for Early Hepatoma in Patients with Chronic Hepatitis and Cirrhosis, Journal of Proteome Research, vol.10, issue.10, pp.4715-4739, 2011. ,
DOI : 10.1021/pr200519q
Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family, PLOS ONE, vol.287, issue.50, 2016. ,
DOI : 10.1371/journal.pone.0148711.s001
Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells, Cancer Research, vol.68, issue.7, pp.2391-2400, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-2460
Epithelial-Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines, Molecular Cancer Therapeutics, vol.11, issue.2, pp.503-516, 2012. ,
DOI : 10.1158/1535-7163.MCT-11-0327
Neuregulin 1 Expression Is a Predictive Biomarker for Response to AV-203, an ERBB3 Inhibitory Antibody, in Human Tumor Models, Clinical Cancer Research, vol.21, issue.5, pp.1106-1120, 2015. ,
DOI : 10.1158/1078-0432.CCR-14-2407
Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies, Oncotarget ,
ErbB-receptors expression and survival in breast carcinoma: A 15-year follow-up study, Journal of Cellular Physiology, vol.2, issue.3, pp.702-710, 2006. ,
DOI : 10.1002/jcp.20535
High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas, Mod Pathol, vol.10, pp.142-150, 1997. ,
Analytic Variability in Immunohistochemistry Biomarker Studies, Cancer Epidemiology Biomarkers & Prevention, vol.19, issue.4, pp.982-91, 2010. ,
DOI : 10.1158/1055-9965.EPI-10-0097
Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1, Molecular and Cellular Biology, vol.22, issue.4, pp.1016-1042, 2002. ,
DOI : 10.1128/MCB.22.4.1016-1026.2002
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation, Proceedings of the National Academy of Sciences, vol.100, issue.20, pp.11285-90, 2003. ,
DOI : 10.1073/pnas.1934283100
Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma, Liver International, vol.21, issue.10, pp.2203-2220, 2015. ,
DOI : 10.1111/liv.12903